[
1. Butler J. Congestive heart failure special issue on advanced heart failure. Congest Heart Fail. 2011;17:159.10.1111/j.1751-7133.2011.00237.x
]Search in Google Scholar
[
2. Tang W, Harper Y, Butler J, Cho L, Hazen S. Risk prediction of incident heart failure in a preventive cardiology clinic: validation of the health abc heart failure risk score with natriuretic peptide testing. Journal of Cardiac Failure. 2010;16:S81.10.1016/j.cardfail.2010.06.283
]Search in Google Scholar
[
3. Yu C, Fung J, Zhang Q, et al. Tissue doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation. 2004;110:66-73.10.1161/01.CIR.0000133276.45198.A5
]Search in Google Scholar
[
4. Athanasuleas C, Buckberg G, Stanley A. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol. 2005;14:37-38.10.1016/j.accreview.2004.12.024
]Search in Google Scholar
[
5. Norris R. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Circulation. 1994;89:1905.10.1161/circ.89.4.8149558
]Search in Google Scholar
[
6. Cohn J, Ferrari R, Sharpe N. Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 2000;35:569-582.10.1016/S0735-1097(99)00630-0
]Search in Google Scholar
[
7. Frangogiannis N. The inflammatory response in myocardial infarction. Nat Rev Cardiol. 2002;53:31-47.10.1016/S0008-6363(01)00434-5
]Search in Google Scholar
[
8. Richards A, Nicholls M, Yandle T, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart. 1999;81:114-120.10.1136/hrt.81.2.114
]Search in Google Scholar
[
9. Tomaselli G. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999;42:270-283.10.1016/S0008-6363(99)00017-6
]Search in Google Scholar
[
10. Nambiar D. Cardiac and extra cardiac predictors and complications of acute atrial fibrillation complicating st elevation myocardial infarction (STEMI) ST elevation myocardial infarction acute atrial fibrillation (STAAF) study. Journal of Medical Science and Clinical Research. 2017;5:22124-22134.10.18535/jmscr/v5i5.139
]Search in Google Scholar
[
11. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol. 2003;91:684-688.10.1016/S0002-9149(02)03404-5
]Search in Google Scholar
[
12. Haque T. Myocardial strain imaging using two and three-dimensional speckle tracking echocardiography: clinical applications. Cardiovascular Journal. 2019;11:167-182.10.3329/cardio.v11i2.40418
]Search in Google Scholar
[
13. Edvardsen T, Helle-Valle T, Smiseth O. Systolic dysfunction in heart failure with normal ejection fraction: speckle-tracking echocardiography. Prog Cardiovasc Dis. 2006;49:207-214.10.1016/j.pcad.2006.08.008
]Search in Google Scholar
[
14. Geyer H, Caracciolo G, Abe H, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23:351-369.10.1016/j.echo.2010.02.015
]Search in Google Scholar
[
15. Blessberger H, Binder T. Two dimensional speckle tracking echocardiography: basic principles. Heart. 2010;96:716-722.10.1136/hrt.2007.141002
]Search in Google Scholar
[
16. Troughton R, Frampton C, Yandle T, Espine E, Nicholls M, Richards A. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. The Lancet. 2000;355:1126-1130.10.1016/S0140-6736(00)02060-2
]Search in Google Scholar
[
17. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.10.1172/JCI1151462951841849149
]Search in Google Scholar
[
18. Daniels L, Maisel A. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice. J Cardiovasc Med (Hagerstown). 2006;7:414-415.10.2459/01.JCM.0000228691.17581.7016721203
]Search in Google Scholar
[
19. Maisel A, Krishnawswamy P, Nowak R. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;11:55.10.1016/S1062-1458(02)00937-6
]Search in Google Scholar
[
20. Neuhold S, Huelsmann M, Strunk G, et al. Comparison of copeptin B-type natriuretic peptide and amino-terminal pro-B-Type natriuretic peptide in patients with Chronic Heart Failure: Prediction of death at different stages of the disease. J Am Coll Cardiol. 2008;52:266-72.10.1016/j.jacc.2008.03.05018634981
]Search in Google Scholar
[
21. Kass DA, Baughman KL, Pak PH, et al. Reverse remodeling from cardiomyoplasty in human heart failure: external constraint versus active assist. Circulation. 1995;91:2314-2318.10.1161/01.CIR.91.9.23147729016
]Search in Google Scholar
[
22. Koitabashi N, Kass D. Reverse remodeling in heart failure-mechanisms and therapeutic opportunities. Nat Rev Cardiol. 2011;9:147-157.10.1038/nrcardio.2011.17222143079
]Search in Google Scholar
[
23. Cinteza M. Reverse remodeling: does this work? Maedica (Buchar). 2015;10:83-84.
]Search in Google Scholar
